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Pseudomonas aeruginosa of human origin has been
found to be antagonistic to Candida albicans from the same
habitat.

In-vitro studies showed the presence of an anti¬

biotic substance produced by Pseudomonas.

Clinical isolates

of these organisms were tested in associative cultures and
while the Candida isolates were uniformly inhibited,
Pseudomonas spp. displayed variability in their inhibitory
capacity.

Sterile filtrates on spent Pseudomonas broth

cultures, when spotted on the surface of Candida seeded
overlays, induced discrete zones of inhibition.
were responsible*

Two compounds

pyocyanine, which exhibits a wide zone

of incomplete inhibition, and phenazine-l-carboxylic acid,
which exhibits a narrow zone of complete inhibition.

It

appears that each compound reinforces the other and together
these are responsible for the inhibitory effect observed
with the crude filtrate.
vi
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INTRODUCTION
The advances made in medicine during the past decade
have been accompanied by an increasing incidence of
opportunistic infections.

Patients acquiring infections

are considered immunologically incompetent and are unable
to defend themselves against the most innocuous organisms.
The indigenous microflora of the healthy individual becomes
life-threatening to those who undergo extensive diagnostic
and therapeutic regimens and prolonged hospitalization.
Recovery from the underlying disease is aggravated by the
complication of infection for which medication is often
ineffective.

Antibiotic resistance among opportunistic

organisms is widely recognized and while a few specific
anti-microbial agents are available, their toxicity restricts
general usage.
Two particularly evident opportunists are Candida
albicans, a yeast, and Pseudomonas aeruginosa, a bacterium.
Presently, there is an increasing incidence of infections
due to these organisms among the severely debilitated
receiving broad spectrum antibiotic therapy.

Eradication

of the normal flora colonizing the respiratory and intestinal
tracts provides an ideal non-competitive habitat for these
opportunists to proliferate.
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The yeast ordinarily occurs in small numbers in the
upper respiratory tract, an environment heavily laden with
a competitive flora.

When this habitat is altered, C.

albicans multiplies and may progress to the lungs.
systemic infections are difficult to control.

Such

Of the two

Candida specific drugs available, nystatin and amophotericin
B, only the latter is effective for systemic infection.
This agent, however,

is exceedingly toxic and is not

generally administered.
The bacterium,

Pseudomonas,

is somewhat similar;

it

is commonly found in moist areas of the inanimate environ¬
ment.

From these sources colonization of the human

respiratory and intestinal tract readily occurs.

Its

significance when found within the healthy host is problem¬
atic, although traditionally,
of the normal flora.

it has been considered part

These and other opportunists present

a diagnostic and therapeutic dilemma to the physician.
Diagnosis must consider not only the organism, their numbers
and relative proportion, but more importantly the ability
of the patient to resist their progress.
Since both Candida albicans and Pseudomonas
aeruginosa are (a) ubiquitous,
sistant to antibiotics and

(b) opportunists,

(c) re¬

(d) have the same temperature

preference, they should, in theory, be regularly isolated
from the immunologically susceptible patient.

We have
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observed that this is not the case.

Either one or the

other, but rarely both, are isolated from the same indi¬
vidual.

This observation led to studies of their associative

behavior, which discloses that Pseudomonas is antagonistic
towards Candida, and attempts to determine the agents
responsible for this antagonism.
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LITERATURE

REVIEW

It is exceedingly unlikely that two populations
growing in the same habitat do not interact.
observation made by Lucas (23) in 1949 that,

The prudent
"Mere toleration

is biologically and statistically improbable," is becoming
increasingly evident.

Neutralism is the term used to

describe associations in which different biological species
coexist, each indifferent to the others presence.

Such

association probably occurs only when the populations are
physically far apart or the physiological requirements are
so different that neither organism exerts an influence on
the other.

As a result, neutralistic associations have

received little interest and have not been systematically
studied (4).
The study of microbial associations has revealed a
variety of possible interactions.

Unfortunately, there is

a tendency to consider these interactions of neutralism,
commensalism, antagonism and synergism as independent and
unchanging.

This

is a major fault, especially in the

assessment of the human microflora, in that rigid criteria
dealing only with benefit or harm are oversimplifications
of complex interactions.

This may be illustrated by the

commensals which colonize the respiratory tract, especially
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the streptococci and yeasts.

While these two organisms

are everpresent they very rarely cause disease.

When disease

does occur it's primarily due to changes on the part of the
host and not to the inherent virulence of the organism.

In

light of this, it is becoming clear that the terms "pathogen"
and "non-pathogen" may also be an oversimplification and
should be replaced with terms which consider both the host
and the organism (9)*

Present understanding of microbial

interactions within the human body is limited, since it is
an ecological problem that must consider not only the
indigenous flora but exogenously acquired organisms as well.
Unfortunately, most of the present knowledge regarding
microbial interactions is the result of in-vitro and bovine
rumen investigations and is extremely limited.
A particularly attractive concept of interaction
has been that of antagonism; associations characterized
by suppression of one organism for the benefit of the other.
In the past decade there has been renewed interest in the
prospect of promoting microbial antagonism not only as a
means of suppressing infectious diseases of man, but also
bacterial control of insects, vermin and rodents.

Due to

the indiscriminate use of pesticides and the problems
attributed to these chemicals, biological control systems
are rapidly gaining favor and much effort is being expended
at the present time developing

appropriate and efficient
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biological control systems.
A considerable amount of work has been reported
utilizing both in-vivo and in-vitro conditions in the control
of infectious diseases by competitive inhibition.

The in-

vivo studies have demonstrated unequivocally that bacterial
interference can be used to augment man's ability to resist
disease.
The terminology used in these studies generally
includes the following*

(1) Test strain—the organism being

antagonized, suppressed or killed;

(2) Effector strain—

the organism responsible for the antagonism and (3)
Bacterial interference—the phenomenon of antagonism by
one organism toward another and synonymous with competitive
interaction.
The concept of infectious disease control by promoting
competitive interaction was first introduced in 1885 by
Contani (8) who attempted treatment of tuberculosis by
replacement of the tubercle bacillus with a mixture of
indigenous species.

In 1906 Emmerich (8) injected beta-

hemolytic streptococci with the prospect of preventing the
spread of anthrax.

Florey's review (8) of the use of micro¬

organisms for therapeutic purposes examines the research of
Metchnikoff and others at the beginning of this century and
discusses the possible reasons for the failure of the concept.
On the other hand, success of this concept is most dramati¬
cally illustrated by the experience of Wagner and Jauregg
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who employed malarial fever therapy for the treatment of
syphillis (6t 32t ^3).
This early era of natural therapy ended in the 1930's
with the development of sulfa drugs and penicillin.

At this

time, interest in microbial antagonism as a means of therapy
was pre-empted by the antibiotic era that followed.

The

concept received little attention until the 196o's when two
discouraging shifts were observed by the clinical micro¬
biologists

(1) antibiotic resistant strains of bacteria

were becoming more prevalent and (2) gram negative bacilli,
formerly considered innocuous, were more frequently documented
as etiologic agents of infectious disease.

These two trends

indicated the limitations of chemotherapy and a renewed
interest in biological control followed.
Shinefield et al (3^»

35) in 1963» were among the

first to reinvestigate biological control when they implanted
avirulent Staphylococcus aureus strain 5°2A on the nasal
mucosa and the umbilicus of newborn infants and successfully
interrupted transmission of epidemic strains among the
nursery population.

The same avirulent strain was also

successfully established in the nasal mucosa of adults who
had previously carried virulent strains of S. aureus.
Staphylocci have also been shown to inhibit a wide variety
of other gram positive bacteria including Corynebacterium
diptheriae and Nocardia species,

y.ycobacterium smegmatis,

Bacillus, Clostridium and other Staphylococcus species
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have been evaluated in competition with S. aureus and were
found susceptible in-vitro (11).
Monosporium apiospermum.a fungus, has been reported
by Cormane et al (7) to be inhibited by both S. aureus and
S.. albus.

It was similarly demonstrated by Prelie that

28 of 30 strains of Neisseria. gram negative cocci, were
inhibited by all 10 strains of S. aureus used in his
studey (29)*

Streptococci, including both the hemolytic

non-hemolytic types other than enterococci, have been reported
susceptible to the antagonism of Staphylococcus species
(36).
Among the protozoa, the blood flukes have been re¬
ported to be susceptible to the effects of certain enteric
bacilli, Klebsiella pneumoniae injected into mice has been
shown to effectively control Shistosomiasis.

Using mice

with an established infection of Shistosoma mansoni. Ottens
and Dickerson (27) demonstrated that intraperitoneal in¬
jection of K. pneumoniae destroyed the fluke in 3 to 4 days.
A positive relationship between the multiplication of the
bacteria in the ceacum and the rapid death of the parasite
was demonstrated.
Another group of antagonistic bacteria are the
streptococci, especially members of the viridans group.
Sanders (31) demonstrated that Streptococcus pyogenes is
is antagonized by viridans streptococci.

Neither the
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phase of growth nor the inoculum size affected the in-vitro
antagonism*

While all group A streptococci were inhibited

by active viridans strains, he reported significant dif¬
ferences in the antagonistic capacity of S. viridans.

He

ascribed this to nutrient depletion and accumulation of
/

acidic end products.

In-vitro studies of children's throat

flora was the basis for his hypothesis that the qualitative
composition of the viridans strains inhabiting the pharynx
is a major determinant of an individual's resistance to
group A streptococcal infections.
Similar observations of the inhibitory capacity of
the viridans streptococci were made by Sprunt (37)•

Evidence

from 10 patients undergoing massive antibiotic therapy
indicated the elimination of viridans streptococci and re¬
placement with Hemophilus influenzae and yeasts.
Kalmanson et al (17) using an agar overlay technique
to demonstrate antagonism were able to effect inhibition of
microbial L-forms.

Emoloying paper discs saturated with

S. faecalis broth, the discs were placed on a nutrient agar
base layer.

An agar overlay seeded with the L-form organism

was then applied over the base layer.
Among the earliest investigations of antagonistic
interactions were those with Pseudomonas as effector strains.
Emmerich and Low (8) using spent cultures of Pseudomonas
found them effective against Bacillus anthracis. Vibrio
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cholerae. Salmonella typhi, C. diptheriae, Pasteurella
pestis and a variety of staphylococci.

They suggested that

the agent responsible was the enzyme "pyocyanase."

It was

later determined that several crystalline pigments belonging
to the phanazine class of compounds were responsible for the
antagonism observed by the earlier workers (33).

Pyocyanine,

the best known of these compounds, is a blue pigment,
extractable with CHCl^ and mildly bacteriostatic.

Like

the other phenazine pigments, it has never been used
clinically as an antibiotic due to its toxicity.
In light of the present dilemma concerning the use¬
fulness and limitations of antibiotics, it is perhaps the
organism and not the extracted products that deserve greater
consideration.

Pseudomonas, in this regard, has been iso¬

lated with regularity from the respiratory tract of healthy
subjects.

Sutter et al (38) recovered this organism from

6.6% of the oral cavities of 350 normal subjects.

The intact

Pseudomonas cell with its capacity to synthesize a variety
of phenazine pigments, each with considerable anti-microbial
activity, might be a significant factor in natural resistance
to disease.
That the usefulness of extracted antibiotics produced
by pseudomonads is limited, was keenly observed by Rosebury
(30) who stated that "—the search for useful antibiotics
among indigenous effectors has been entirely fruitless."
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This seems especially significant when one considers that
Ps. aeruginosa was the first indigenous microorganism to
disclose antibiotic effects (7)*

Nevertheless, this

organism, as an effector strain, has the capability to
produce antibiotics while most indigenous effectors either
elaborate major metabolites, such as ethanol, or compete
for vital nutrients.

Also significant is the ability of

Pseudomonas species to synthesize pyocines, which are active
against other strains of the same species.
Candida, with its well-known capacity to inhabit
man as either a pathogen or commensal, is another organism
which must be included in this consideration of interactive
phenomena (21).

Of particular concern is its widespread

resistence to antibiotics.

The new drugs presently available

and relatively effective against Candida are Mycostatin and
Amphotericin B.

Mycostatin is limited to superficial

infections; cases often as effectively treated with po¬
tassium permanganate or crystal violet preparations.
Amphotericin B is used for systemic candidiasis but its
toxicity severely restricts its usage.

For these reasons the

physician is reluctunt to prescribe these drugs and tends to
manage a regimen which treats the underlying disease to which
Candida is often secondary (13* 27)*
As a participant in microbial interactions, Candida
is known to exhibit both stimulative and inhibitory effects.
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The vitamin components and the amino acids elaborated are
apparently responsible for the stimulatory effect (29).
Lactobacillus species and Neusseria catarrhalis are known
to benefit from a wide variety of associations, one of
which is with C. albicans (30, 42).

Escherichia coli is

similarly stimulated by the presence of C. albicans.
Candida, on the other hand, is inhibited by its presence.
Rosebury et y. (30) reported that E. coli grew luxuriantly
in association with Candida on Douglas Lactate agar.

When

E. Coli was cultivated separately, no growth was observed.
Inhibition of Candida may be ascribed to competition
for nutrients.

In a study using fresh saliva, sterile and

contaminated, growth of Candida was determined to be
directly proportional to the concentration of salivary
glucose.

Peak growth of Candida was observed on sterile

saliva and could only be induced on contaminated saliva
if glucose was added (20).

However, with the Candida-

Lactobacillus association, it has been observed that Candida
inhibition was due to the concentation of excess lactic acid
and hydrogen ions (42).
As an antagonist, Candida may produce an antibiotic
which inhibits N. gonorrhea.

Genital tract specimens often

contain both of these organisms and yet growth of Neisseria
is often diminished or entirely prevented when in competition
with Candida, a phenomenon not evident when Candida is absent.
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An inhibitory factor not yet identified but presumably
an antibiotic has been extracted with tertiary butanol (14).
The significance of metabolites such as ethyl
alcohol as inhibitory agents when synthesized in-vivo has
not been reported although blood alcohol levels of 0.02$
EtOH have been found post mortem apparently synthesized
by C. albicans (36).
In the studies of antagonistic interaction it is
apparent that three possible mechanisms of inhibition may
be operative:

(1) depletion of nutrients essential to the

associate organism,

(2) elaboration of a major metabolite

with the creation of a restrictive physiological condition
and (3) synthesis of an antibiotic substance.

While any one

of these may not be difficult to demonstrate in-vitro, the
evidence for their in-vivo action is indirect and circum¬
stantial.
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MATERIALS

AND

METHODS

Organisms
Most of the microbial cultures employed in this
study were obtained as fresh clinical isolates.

The bac¬

terial and yeast strains studied are listed in Table 1 and
were maintained on slants of Stock Culture agar (Difco),
at ambient air temperature and transferred monthly.
The organisms were characterized using standard
bacteriological tests as described in the Manual of Clinical
Microbiology by Blair et al (2).

All media were freshly

prepared from a dehydrated base (Difco) and reactivity
confirmed before use.
The Candida isolates were initially isolated on
Tryptose Blood agar (TBA, Difco) and transferred to Sabouraud Dextrose agar (Difco) for separation.

After 24 hours

incubation at 37C, purity was ascertained by visual in¬
spection and a single colony used as inoculum for the
following procedurest

germ tube production, BIGGy agar

(Difco) reaction, carbohydrate utilization, chlamydospore
production and urease activity.

Only those isolates pro¬

ducing reactions consistent with C. albicans were retained
in the culture collection.
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TABLE 1
CLINICAL ORIGINS OF EFFECTOR
AND TEST ORGANISMS

Effector Strain

Origin

Ps. aeruginosa 69467

respiratory tract

Ps. aeruginosa 69326

urinary tract

Ps. aeruginosa 68114

respiratory tract

Ps. aeruginosa 100

respiratory tract

Ps. aeruginosa 68084

tracheostomy incision

Ps. aeruginosa 69616

urinary tract

Ps. aeruginosa 67650

respiratory tract

Ps. aeruginosa 68394

respiratory tract

Ps. aeruginosa 69376

tracheostomy incision

Ps. aeruginosa 69322

respiratory tract

Ps. aeruginosa 69386

urinary tract

Test Strain
C. albicans 68656

respiratory tract

C. albicans 68443

genital tract

C. albicans 67324

urinary tract

C. albicans 67578

urinary tract

C. albicans 68340

respiratory tract

C. albicans 67624

genital tract

C. albicans 67626

respiratory tract

C. albicans 68236

respiratory tract

C. albicans 68277

urinary tract

C. albicans 68366

urinary tract

C. albicans 68298

gastrointestinal tract

C. albicans 68655

respiratory tract
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The Pseudomonas isolates were also recovered from
TBA plates inoculated with clinical material.

Colonies

resembling Pseudomonas were transferred to Meuller Hinton
agar (MH, Difco) and after 24 hours incubation a single
colony was used as inoculum for the following determinations:
reaction in O/F Medium (Difco) containing glucose, motility
in a hanging drop preparation, ketogluconate exidation (Key
Scientific) and cytochrome oxidase reaction using p-amino
dimethylaniline oxalate reagent.

Confirmed isolates of

Ps. aeruginosa were then transferred to the stock culture
collection for further study.

Associative Cultures
Initially the interference phenomenon was observed
on solid media.

Peptone agar plates were inoculated with

a single diametric streak of Pseudomonas, after 24 hours
incubation the agar was inverted using the "flip-flop"
method reported by Kekessey and Piquet (15)•

The agar was

loosened with a sterile spatula and inverted into the lid
of the petri dish.

Candida was then streaked onto the ex¬

posed agar surface perpendicular to the original Pseudomonas
streak.

The plate was again incubated at 37 C and the

inhibition noted.
A variety of in-vitro techniques, utilizing either
liquid or solid media, have been devised to demonstrate
interference among microorganisms (29)*

In this phase,
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liquid cultures were utilized in three studies in order to
evaluate the routine methods employed to demonstrate this
antagonism.
The first quantified the growth of Candida on
sterile spent Pseudomonas broth and also the growth of
Pseudomonas on similarly prepared Candida broth.

A 500 ml

Erlenmeyer flask containing 100 ml of Brain Heart Infusion
(BHI, Difco) was inoculated with a BHI culture of Pseudomonas
aeruginosa 100 that was incubated overnight at 37 C.

A

second flask was similarly inoculated with C. albicans
67324.

Both flasks were incubated for 48 hours as sta¬

tionary cultures at 37 C.

The spent broths were then

filter sterilized (Millipore 0.45 mu pore size) and a two¬
fold serial dilution extending to 1:128 in 16x150 mm test
tubes was prepared and inoculated with the alternate
organism.

After 72 hours the organisms in each tube were

quantified by serial dilution in 0.85$ saline.

Blood agar

pour plates were seeded with 0.1 ml of each dilution and
incubated for 24 hours at 37 C.

Results are presented as

arithmetic means of duplicate counts and expressed as colony
forming units per ml (CFU/ml).
In the second trial, Ps. aeruginosa 100 and C.
albicans 67324 were inoculated into separate flasks, 1 ml
of an overnight BHI culture was added to 200 ml of BHI and
incubated at 37 C for 24 hours.

The flasks were then cross
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inoculated with the alternate organism using 1 ml of an
overnight BKI culture.

72 hours and 6 days.

The flasks were sampled at 24, 48,
Cne-tenth ml of each was used as

inoculum for duplicate "blood agar plates.

After 24 hours

incubation at 37 C the plates were examined qualitatively
for the presence of Pseudomonas and Candida.
The third trial consisted of three 500 ml Erlenmeyer
flasks each containing 100 ml of BHI broth.

The first flask

was inoculated with 1 ml of Fs. aeruginosa 100 standardized
to contain 25 cells per ml.

The second flask was inoculated

with C. albicans standardized to contain 24 cells per ml.
The third flask received 1 ml each of the Pseudomonas and
the Candida standardized inocula.

The flasks were incubated

at 37 C for 30 days and sampled at regular intervals.
fold serial dilutions ranging from 1x10"^ to 1x10”

Ten-

were

made and smeared onto KH agar and Molybdate Agar plates
(Hospital Service Technology, North Andover, Mass.) for
quantification (expressed as CFu/ml).

Overlay Technique
Detection of interference in liquid cultures proved
to be an unwieldy technique.

This difficulty was overcome

by adopting the agar overlay method, the virtue of which lies
in its simplicity and sensitivity.

The first method employed

was that of Osman's (26) which utilized a 6 ml nutrient
base layer in a standard petri plate covered with 3 nil of
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serai-solid {0.67%) agar previously seeded with two drops
of an overnight broth culture of the test organism.

The

medium after solidification was placed in an incubator
at 37 C for 90 minutes to dry.

Drops of filtrate from

effector strains of antagonistic microorganisms were placed
on the surface and when dry, the plates were inverted and
incubated at 37 C overnight.

This technique lacked sensi¬

tivity to detect weakly antagonistic effector strains and
was modified after the following studies were completed.
1.

Base layer components.

Three modifications were

examined for enhancement of overlay zone development.

The

first compared nutritionally complete MH medium to Nutrient
agar (NA, Difco).

Ten ml of each medium were pipetted into

standard petri plates and after hardening, 3 ml of 0.8%
agar was used for the overlay.

The second examined the

effect of pH ranging from 4 to 8.

Acid reactions of pH 4

and 6 were prepared by adding 2 N tartaric acid dropwise
to sterile liquid (40 C) medium.

Alkaline media with a

pH reaction of 8 was prepared by the addition of 1 N
sodium hydroxide.

Ten ml of each adjusted preparation were

pipetted into standard petri plates, allowed to harden, and
the agar overlay applied as before.

The third utilized five

different base layer volumes of MH agar (5»
25 ml per plate).
was applied.

10»

15» 20 and

After hardening, a 3 ml agar overlay
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In all of the above, the overlay consisted of 0.8%
bacteriological grade agar prepared in 100 ml of distilled
water seeded with 1 ml of an overnight broth culture of
C. albicans 67324.

When solidified, the overlay surface

was spotted dropwise with sterile spent broth of Ps.
aeruginosa 100.

After overnight incubation at

37 C, zones

of inhibition were measured with metric calipers.
2.

Filtrate application and overlay agar volume.

Using a base layer of MH agar (10 ml), both

3 and 6 ml

volumes of overlay agar were compared for zone development.
C. albicans 67324 was seeded as before and the agar allowed
to solidify.

Using a microliter syringe

(Hamilton Model

710-LT, The Hamilton Co., Reno, Nevada), 10, 20,

3°» 40

and 60 microliter volumes of filtrate were applied to the
plates prepared with

3 nil of overlay agar.

were incubated overnight at

All plates

37 C and zones of inhibition

measured.
3*

Effector strain filtrate.

Two hundred ml

of BHI broth contained in a 500 ml Erlenmeyer flask was
inoculated with 1.0 ml of an overnight BHI broth culture
of Ps. aeruginosa 100 and incubated at 37 C for 14 days
as a stationary culture.

A very viscous gel accumulated

during this time which required primary filtration with
coarse Whatman No. 1 rapid flow filter paper prior to
membrane filter sterilization (Millipore, 0.45 urn pore
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size).

The resulting preparation, unless used immediately,

was stored at -20 C.
To replenish the supply of filtrate, the preparation
procedure was repeated at regular intervals throughout the
experimentation.

A pool was established and all filtrate

/

harvested was added to it; the pool was labeled "Pool X."
As needed, the pool was thawed at room temperature and an
aliquot removed.

The pool was then promptly refrozen and

maintained at -20 C.
4.

Modified overlay technique:

final version.

Ten ml of MH agar was poured into standard petri plates
and allowed to solidify.

Then 3 ml of 0.8$ bacteriological

grade agar seeded before solidification (40 C) with 1 drop
of an overnight BHI broth culture of Candida albicans was
used as the overlay.

This layer was allowed to set and dry

with the petri plate cover slightly ajar for 30 minutes at
room temperature.

Drops of Pseudomonas filtrate prepared

as previously described on sterile blank paper discs (BBL,
Baltimore, Md.) saturated with filtrate were applied to
the surface.

The plate covers were left slightly ajar

until the filtrate had dried, then the covers were closed
and the plates incubated at 37 C overnight.

Zones of

inhibition were measured in millimeters diameter.
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Characterization of the Antagonistic Phenomenon
Using the overlay technique, further studies of the
antagonistic phenomenon were implemented to characterize
the Candida-Pseudomonas interaction and to ascertain the
conditions which enhance the antagonism of Pseudomonas
and the susceptibility of Candida*

Also explored was the

antagonistic effect of Pseudomonas on other microbial
species.
1.

Interaction:

variation among strains.

The

Pseudomonas and Candida strains listed in Table 1 were
screened to select those exhibiting maximum interference.
The 11 strains of Pseudomonas and 12 strains of Candida were
evaluated as effector and test strains, respectively.

The

degree of interference was judged on a scale of 0 to 3 to
facilitate the selection process.

The test and effector

strains selected were used exclusively in the studies that
followed.
2.
species.

Antagonistic spectrum toward other microbial
Eleven fresh clinical isolates, randomly selected

to serve as test organisms for Pseudomonas, were inoculated
into sterile BHI broth (8 ml) and incubated overnight at
37 C.

These test species included:

Ps.

iodium, S. viridans,

S. pyogenes, S. Faecalis, S. aureus, E. coli, Herella vaginicola,

Proteus mirabilis, K. pneumoniae and C. albicans♦

One drop of each broth culture was added to 3 ml of overlay
agar in the procedure that followed.
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3*
filtrate.

Conditions favoring the production of active
This series of experiments examined the condi¬

tions which enhanced the antagonistic effect of Pseudomonas.
Three 250 ml Erlenmeyer flasks containing 25, 50 and 150 ml
of BHI broth were prepared and inoculated with 1 ml of an
overnight BHI broth culture of Ps. aeruginosa 100.

The

flasks were incubated as stationary cultures at 37 C and
3 ml aliquots were harvested at the following times:
4, 6, 9,

12,

14 and 20 days.

1, 2,

The aliquots were sterilized

by membrane filtration and assayed using the overlay tech¬
nique previously described.

As in all of the procedures

that follow, only discreet zones of complete inhibition
were measured and recorded.
Incubation temperature variables were evaluated to
establish the optimum for inhibitory activity.

Three 500

ml Erlenmeyer flasks each containing 100 ml of BHI broth
were inoculated with 1 ml of an overnight broth culture
of Ps. aeruginosa 100 and incubated for 14 days at 30» 34,
and 37 C.

Aliquots were harvested, filtered and assayed

using the overlay technique.
The formulation pH of BHI broth (7.4) was compared
to adjusted levels of pH 6.4 and pH 5*4 to ascertain its
effect on spent broth activity.

Three 500 ml Erlenmeyer

flasks each containing 200 ml of BHI broth were adjusted
to the desired pH using 2 N tartaric acid.

They were each
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inoculated with 1 ml of an overnight BHI broth culture
of Ps. aeruginosa 100 and incubated at 37 C for 14 days.
After harvesting, the sterile filtrate was assayed for
activity using the overlay technique.
Five media were evaluated for their potential as
spent broth substrates*
glucose),

BHI {0,2% glucose), BHI (1.0%

Pseudomonas F broth, Pseudomonas P broth and Nutri

ent broth (Difco)j the latter three media contained no
glucose.

One hundred ml volumes of each were prepared in

500 ml Erlenmeyer flasks and inoculated with 1.0 ml of an
overnight broth culture of Ps. aeruginosa 100 BHI.

The

flasks were incubated for 14 days at 37 C, harvested,
filtered and assayed for activity.
4.

Candida susceptibility as a function of

incubation time.

Two 500 ml Erlenmeyer flasks each con¬

taining 100 ml of BHI broth and inoculated with 1 ml of
an overnight BHI culture of C. albicans 67324 were pre¬
pared.

One flask was incubated for eight days and the

other for one day.

Both flasks were harvested, filtered

and assayed simultaneously.

The standard overlay procedure

was followed.
Characterization and Purification of the Active Principle
1.

Cell free extract.

Ps. aeruginosa cells grown

in 1300 ml of BHI broth for 5 days at 37 C were harvested
by centrifugation at 8000 x g for 10 minutes in a Sorvall
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RC-2B refrigerated centrifuge.

The supernatant was dis¬

carded and the pellet of cells suspended in distilled
water,

0.1 g (wet weight)/ml.

The suspension was disrupted

by 5 minutes of sonic oscillation (Biosonic, Bronwill
Scientific Co.).

The preparation was then passed through

a French pressure cell (Wabash Metal Products, Wabash,
Indiana) at 5000 lb/in

after which the cell debris was

removed by centrifugation at 6500 x g.

The supernatant

was retained for assay of anti-candidal activity.
2.

Dialysis.

Spent broth was dialyzed using two

types of membrane tubing:
Scientific,

natural cellulose (Fisher

Pittsburgh, Pa.) which retains molecules with

a molecular weight exceeding 12,000 and regenerated cellu¬
lose (Fisher Scientific) retaining molecular weights ex¬
ceeding 3,500.

Twenty ml of filtrate

(Pool X) added to

each dialysis sac was dialyzed for 24 hours in 500 ml of
distilled water at 6 C.

Aliquots were removed and spotted

on overlay agar along with an untreated sample.
3*

Trypsinization.

One ml of freshly prepared

5$ trypsin (Schwarz/Mann, lot #3910) was added to 9 ml
filtrate

(Pool X) and incubated at 37 C for 24 hours.

Another 9 ml of filtrate with 1 ml of saline added,
stead of trypsin, served as a control sample.

The

preparations were assayed using the standard overlay
technique.

in¬
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4.

Thermal stability.

The heat stability of the

inhibitory compound produced by Pseudomonas was evaluated
after heating aliquot6 of filtrate at 56» 68, and 100 C
for 45 minutes and storing at 6 and -20 C for 12 days.
5.

Stability to acid,

light and desiccation.

A

1.0 ml aliquot of filtrate (Pool X) was treated with IN
H2S0^ until pH 5 was obtained.

After 15 minutes,

0.5 ml

was removed and neutralized with 2 N NaOH to pH 8 and
held for 15 minutes.

An untreated aliquot of filtrate

pH 8.3 (natural pH) served as a control sample.

All

preparations were then assayed for activity.
Stability to light and desiccation was determined
by spotting cellulose polyacetate electrophoresis strips,
1" X 6" (Gelman Instrument Co., Ann Arbor, Michigan), with
30 microliters of filtrate.

The strips were allowed to

dry and remain exposed to the air and artificial light of
the laboratory for five days.

After exposure, the strips

were appressed to the overlay agar surface along with
control strips spotted with fresh filtrate.

After incu¬

bation overnight at 37 C, the strips were removed and the
plates re-incubated for 24 hrs

for further growth of

Candida.
6.

Zone electrophoresis.

Separation of the

bio-active principle was attempted by electrophoresis on
cellulose acetate strips (Sepraphore III) using an electro-
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phoresis chamber (Gelman Instrument Co., Ann Arbor,
Michigan).

Twenty microliter samples of Pseudomonas fil¬

trate (Pool X) were applied to the strips and allowed to
dry.

The strips were moistened in buffer and stretched

across the chamber.

A 0.25 microliter sample of RBY

reference dye solution (Gelman Instrument Co.) was then
applied to one end of a control strip and 175 volts were
applied to the system for 45 minutes.

The strips were

removed and cut in half, each piece was then appressed to
the surface of a freshly seeded C. albicans overlay agar
plate and incubated for 24 hours at 37 C.

The strips were

then removed and the plates reincubated for an additional
24 hours to enhance the growth of Candida.
7*

Extraction technique.

To determine the polar

nature of the active agents responsible for inhibition of
Candida, three organic solvents were used.

Nine 100 ml

extraction flasks, each containing 20 ml of filtrate (Pool
S) were divided into three groups.

The first group was

adjusted to pH 3* and the second to pH 7 using IN H^SO^.
The third group was adjusted to pH 9 using 2 N NaOH.

The

solvents used were hexane, diethyl ether and butanol
(analytical grade).

Twenty ml portions of each solvent

were added to one flask of each group and after 2 minutes
of hand shaking, the phases were allowed to separate.

The

aqueous phase was retained and extraction repeated, after
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which the aqueous phase was separated, placed in a petri
dish and allowed to air for 30 minutes.

The nine prepara¬

tions were then assayed for residual activity.
A second extraction scheme was followed using only
chloroform as the solvent.

Six ml of filtrate, adjusted

to pH 2 using 6 N HC1 were extracted with 6 ml of CHCl^.
The CHCl^ phase, after separation, was evaporated for 3
hours in a watch glass containing 4 blank paper discs.
The aqueous phase remaining after extraction was adjusted
to pH 10 using 6 N NaOH and extracted again with CHCl^.
The discs were then assayed for activity using the overlay
technique.
The third approach to the selection of solvents
was based on the observation of crystalline inclusions
within colonies of Pseudomonas cultured on MH agar.

After

4 to 6 days incubation, the agar plates were examined under
low microscopic magnification (100 X), various organic
solvents were added and dissolution of the crystals was
noted.
The information gained from these preliminary studies
prompted the investigation to follow an extraction scheme
for the phenazines (Fig. 1) as reported by Chang and
Blackwood (5)«

Ten microliters of extract were spotted on

thin-layer chromatography plates coated with 0.25 mm of 3IL
G-25 silica gel without gypsum (Brinkman Instruments,
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Culture liquor
4 N HCL
to pH 2
CHCL^ extraction

CHCL^ layer

H^O layer
NaHCO^

5% NaHCO^

to neutral

r
NaHCO^

CHCL^ extraction
I

j

CHCL^ layer

-1
CHCL^layer

.

4 N HCL
to pH 2

H20 layer

CHCL ext'n
t.l.c.(silica gel)
CHCL3:MeOH(9:l)
elute corresponding band
0.2 N HC1

P
H20

-1
CHCL0 layer
i 3
t.l.c.(silica gel)
CHCL
;Me0H (9*1)
elute corresponding
band (0.2 N NHk OH)
1
4
t.l.c.

t.l.c.

i

elute corresponding
band

elute corresponding
band

Pyocyanine

Phenazine-1carboxylic acid

Fig.

1.

Scheme for Separation of Two Phenazine Pigments.
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Westbury, N.Y.).

The bands were compared to reference

pigments simultaneously chromatographed.
Identification Techniques
The band corresponding to Pyocyanine was rechromatographed and eluted as previously described.

This

was followed by crystallization from cold CHCl^ with the
addition of petroleum ether.

The melting point of the

crystalline product was obtained with a microscope and a
Kofler hot stage apparatus.

The absorption maxima of the

product in 0.2 N HC1 was measured on a Beckman DU model
2400 spectrophotometer.

Both reference and isolated com¬

pounds were developed on Brinkman thin layer chromatograms
/

using CHCiy.leOH solvent mixture

(9si) and their rf values

compared.
The band corresponding to phenazine-l-carboxylic
acid was rechromatographed and eluted with 0.1 M NaOH.
A melting point determination using a capillary tube
apparatus was attempted, however, after reaching 360 C the
product was presumed to be a salt.

After redissolving in

6 N HC1 and extracting with CHCl^ the preparation was
allowed to evaporate.

The pigment was then crystallized

from cold MeOH and the melting point with a correction
factor of 0.5 C was successfully determined.

The crystalline

appearance was compared to authentic samples of phenazinel-carboxylic acid.

The absorption maxima were measured

in
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0.2 N HC1.

Following this the sample was chromatographed

along with authentic samples using the same TLC procedure
as described above for pyocyanine.
Biological activity of all bands was verified by
scraping from the thin-layer chromatogram visualized with
an ultraviolet lamp (Blak-Ray, model UVL-22,

366 nm wave¬

length, Ultraviolet Products, Inc., San Gabriel, Calif.).
The scrapings were collected in a pasteur pipette packed
with a small quantity of acid-washed glass wool to prevent
loss of the powder.

The band corresponding to pyocyanine

was eluted with 0.1 N HC1 while that corresponding to
phenazine-l-carboxylic acid was eluted with 0.1 N NaOH.
Each eluate was absorbed on three blank paper discs and
when dry were assayed for inhibitory activity using the
standard overlay technique.

Inhibition zones were com¬

pared to those obtained with authentic pyocyanine and
phenazine-l-carboxylic acid.

Both reference compounds were

prepared in four concentrations (250, 25» 2.5 and 0.25
mcg/ral) in 0.1 ml of 0.1 N NaOH and added dropwise to the
overlay agar surface.

Reference Compounds
Pyocyanine was purchased from Schwarz Mann,
Orangeburg, N.Y.

Phenazine-l-carboxylic acid was a gift

from Frederick Helliman, Department of Organic Chemistry,

the University of Leeds, Leeds, Scotland.

The organic

solvents and other chemicals used were analytical grade.
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RESULTS

Overlay Technique
Five variables were examined in the development of
this technique and are summarized in Table 2.

It can be

seen that acidification of the base layer resulted in
complete loss of inhibitory activity.

On the other hand,

MH medium at pH 7.4 induced a larger inhibitory zone than
that obtained at pH 8.0.
The overlay agar and base layer volumes were in¬
versely proportional to the resulting zone size.

Some

difficulty was experienced in preparing a 3 ml overlay of
uniform depth.

The problem was alleviated by pouring the

overlay shortly after the base layer had solidified and was
still warm.

The volume of filtrate applied appeared to be

stoichio-metrically related to the inhibition zone obtained.
Results of the media evaluation indicated that the more
enriched MH agar induced larger zones of inhibition than
those obtained with nutrient agar.

Conditions for Interaction
As revealed in Table 3» serial dilution of inhi¬
bitory filtrate was accompanied by a progressively increased
growth response by C. albicans.

On the other hand,

Ps.

aeruginosa exhibited a diminished growth response in serial
dilution of C. albicans filtrate.

These findings indicate
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TABLE 2
OVERLAY TECHNIQUE VARIABLES AND THEIR EFFECT
ON INHIBITION ZONE DEVELOPMENT

Variables evaluated

Inhibition zone

pH (base layer)
4.0
6.0
7.4
8.0
Overlay volume

0
0
15.7
13.6
(ml)

3.0
6.0
Base layer volume

9.1
6.0
(ml)

5-0
10.0
15.0
20.0
25.0

20.8
17.0
14.5
11.0
8.5

Filtrate volume (ul)
10
20
30
40
60

0
6.0
8.5
12.0
14.5

Medium
KH
Nutrient agar

a Zone diameter in millimeters.

15.7
13.1
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TABLE 3
EFFECT OF FILTRATE DILUTION ON
GROWTH OF ASSOCIATE ORGANISM

Plate counts
Reciprocal of
filtrate dilution

Candida (CFU 10^)

2

6.0

146.5

4

14.0

8O.5

8

36.5

75.0

16

32.0

53.5

32

35.0

62.5

64

46.5

57.5

128

63.0

55.5

Pseudomonas (CFU 10^)
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that in associative cultures,

Candida is inhibited while

Pseudomonas is stimulated.
The intent of this study was to determine whether
the inhibitory activity of the filtrate was due to the
development of physiological and chemical changes (in¬
cluding substrate depletion) in spent broth or the
elaboration of an antibiotic substance.

Since the serial

dilution of the spent broth was accompanied by a commenf

surate growth response of Candida,

it was hypothesized

that an antibiotic substance was responsible for the in¬
hibition.
The second experiment examined the effect of
inoculating each species into established cultures of the
alternate species (Table 4).

While Ps. aeruginosa was

capable of establishing itself in an actively growing
culture of C. albicans, Candida could not be established
in an actively growing culture of Ps. aeruginosa.
To further confirm this antagonistic interaction,
growth curves of the two organisms growing separately and
together were plotted.

In this case the mixed culture was

established by simultaneous inoculation, a method outlined
by Guze, et

(?).

As can be seen in Fig. 2, C. albicans

survived but exhibited a diminished population when com¬
pared to growth in pure culture.
suggest that Candida,

The foregoing studies

if given time to establish
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TABLE 4
ISOLATION OF C. ALBICANS AND PS. AERUGINOSA
FROM ASSOCIATIVE CULTURES ORIGINALLY
ESTABLISHED WITH A SINGLE SPECIES

Organism recovered
Time after
assoc, culture
inoculated

Culture
originated
as s

C. albicans

Ps. aerug.

1 day

Candida
Pseudomonas

+a

+
+

2 days

Candida
Pseudomonas

+

+
+

3 days

Candida
Pseudomonas

+

+
+

6 days

Candida
Pseudomonas

+

+
+

a+ growth
- no growth

BACTERIAL

POPULATION
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TIME- DAYS

Figure 2,
in

Growth

of

the presence of

C. al bi cans

alone

Ps_. aerugi nosa ,

and

BACTERIAL POPULATfON
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Figure

3

Growth of Ps, aeruginosa alone and

in the presence

of

C. albicans .
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logarithmic growth can adapt to the introduction and
development of Pseudomonas.
The antagonistic spectrum of Pseudomonas toward
randomly selected organisms is shown in Table 5.

The

diversity of susceptible organisms further supports the
hypothesis that the active principle was an antibiotic and
not a bacteriocin or a phage.
The survey of conditions optimum for the yield of
the hypothesized antibiotic indicated that the incubation
time for stationary cultures must extend beyond 4 days
(Table 6).

The highest yield was obtained from a 14 day

old culture although activity was still detectable at 20
days.

These findings are similar to those of other workers

who reported that old cultures of Pseudomonas were highly
"bacteriocidal" to many organisms (39» 4l).

Also shown in

Table 6 is the correlation between yield and medium volume.
Since no activity was observed in the very shallow (25 ml)
culture flask,

it appears that the redox potential may

influence the synthetic pathway of the antibiotics.
The data in Table 7 show that of the 3 temperatures
evaluated for the incubation of Pseudomonas,
the most potent filtrate.

30 C yielded

Approximately 84$ of this

activity was detected at 34 C and only 50$ at 37 C.

These

observations are in accord with those made by Chang and
Blackwood while investigating the phenazine pigment (5)»
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TABLE 5
ANTIMICROBIAL SPECTRUM OF
PSEUDOMONAS FILTRATE

Test Organism

Range

Mean2

Candida albicans

14-I5b

14.4

Escherichia coli

14-16

15.0

Herellea vaginicola

12-13

12.6

Klebsiella pneumoniae
Froteus mirabilis
Pseudomonas iodinium
Staphylococcus aureus

0
16-1?
0

15-17

0
16.8
0
16.0

Streptococcus faecalis

0

0

Streptococcus pyogenes

0

0

Streptococcus viridans

0

0

aZone diameter of five replicate plate counts.
^Zone diameter in millimeters.
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TABLE 6
THE EFFECT OF INCUBATION TIME AND MEDIUM VOLUME
ON THE DEVELOPMENT OF FILTRATE POTENCY

Incubation
Time
(days)

Medium Volume
25 ml

50 ml

150 ml

1

0

0

0

2

0

0

0

4

0

indiscreet zones

6

0

7.8a

7.0

9

0

7-7

9.1

12

0

5.6

7.4

14

0

8.6

10.9

20

0

6.2

8.4

a

Zone diameter in millimeters.
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TABLE 7
THE EFFECT OF INCUBATION TEMPERATURE ON
FILATRATE POTENCY DEVELOPMENT

Pseudomonas Incubation

Range

Mean

30

13-l6a

15.2

34

10-14

12.8

37

5-io

7.2

Temperature

C

Q

Zone diameter in millimeters.

Kluyver (19) made a similar observation in his studies
using Ps. aureofaciens as the effector strain.

He noted

that 30 C was optimal for both growth and pigment (anti¬
biotic) production, while 35 C yielded satisfactory growth
but no detectable pigment.
No difference in activity was noted in the filtrate
prepared from BHI broth adjusted to pH levels of 5*^» 6.4
and 7*4.

On the other hand, evaluation of various media

and the resultant filtrate activity revealed that only
BHI broth yielded detectable inhibition.

While it has

been reported that glucose or glycerol in concentrations of
1-8$ are necessary for quantity production of the phenazine

pigments (9)*

it should be noted that none of the other

media contained carbohydrate.
The final condition examined was the effect of
incubation time on the susceptibility of C. albicans to
pseudomonas pigments.

Table 8 shows three growth phases

of Candida (exponential, stationary and death) which were
used to seed the agar overlay.

While there was essentially

no difference in the data obtained between the stationary
and death phases, the susceptibility in the exponential
phase was approximately 10$ less than that of the stationary
phase.

This observation substantiates the data obtained

from associative cultures showing the adaptability of
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TABLE 8
THE RELATIONSHIP BETWEEN INCUBATION TIME
OF C. ALBICANS AND ITS SUSCEPTIBILITY
TO PSEUDOMONAS FILTRATE

C. albicans
Growth Phase

Susceptibility
Range

Mean

Exponential
24 hrs.

14-I7a

15-5

Stationary
48 hrs.

17-18

170

Death
28 days

17-19

17.6

a

Zone diameter in millimeters.
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Candida in its early growth phases.

Agents Responsible
While the foregoing results of interactive phenomena
seem to indicate that an antibiotic agent was responsible,
more conclusive evidence was established upon the completion
of the extraction and purification techniques.

Character¬

ization prior to these techniques showed that the active
principle in the filtrate was not an enzymatic or protein¬
aceous agent.

Trypsinization did not affect the bioactivity

nor did any of the thermal treatments.

The substance was

stable on exposure to light and dessication and the molecular
weight as indicated by dialysis was less than 3»500.
Definitive data were not obtained from studies using cellfree extract nor was the separation technique using zone
electrophoresis successful.

Neither investigation was

pursued further and the data are not presented.
The activity was completely lost on acidification
of the filtrate to pH 5»

After reversal to 8.3 (original

pH), activity was restored and comparable to the untreated
control sample.

These findings supported the observations

made in the development of the overlay technique where an
acid pH base layer completely neutralized antibiotic
activity (Table 9)»
Crystalline inclusions within colonies of Pseudomonas
growing on MH agar proved to be soluble in CHCl^# sparingly
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soluble in butanol and not soluble in hexane as observed
by microscopic examination (100 X).
The extraction scheme of Chang and Blackwood
yielded two bio active products:

(1) deep blue rhembic

crystals soluble in CHCl^ and hot water, consistent with
pyocyanine and

(2) yellow, needle-like crystals, soluble

in CHCl^ and alkali, consistent with phenazine-l-carboxylic
acid.

Although a number of

other spots were observed

when these crude extracts were chromatographed only these
two compounds were active against C. albicans.

The

physiochemical properties obtained after the final
crystallization are compared with authemtic samples
(tables 10,11).

As; can be seen, both the isolated and the

reference compounds behaved identically.
derivatives were prepared.

As further proof,

A semi-carbazone from pyocyanine

and an amide from phenazine-l-carboxylic acid showed rf
values similar to derivations of the isolated pigments.

48

TABLE 9
THE EFFECT OF ACIDIFICATION ON THE
DEVELOPMENT OF FILTRATE POTENCY

Inhibition zone
pH manipulation

8.3

5.0

8.3

5.0

8.3 (control

a

Range

no inhibition
8.3

Mean

no inhibition

16

-

20a

18.6

18

-

21

19.6

Zone diameter in millimeters.
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TABLE 10
PROPERTIES OF EXTRACTED AND AUTHENTIC
PYOCYANINE PIGMENT

t

Isolated
pigment

Authentic
pyocyanine

Appearance

dark blue
needles

dark blue
needles

Melting point C
with correction
factor 0.5 C

132-132.5

132-132.5

390, 278

390, 279

CHCly hot water

CHC13, hot

Absorption maxima
mu in 0.2 N HCL

Solubility

water
TLC*

rf

TLC:
rf deriv.
semi-carbazone

•55

•55

.65

• 63

50

TABLE 11
PROPERTIES OF EXTRACTED AND AUTHENTIC
PHENAZINE-l-CARBOXYLIC ACID

/

Isolated
pigment

Authentic
pigment

Appearance

yellow needles

yellow needles

Melting point C
with correction
factor 0.5 C

239

239

Absorption maxima
mu in 0.2 N HCL

368, 253

368, 251

Solubility

CHCly NaOH

CHCl^, NaOH

rf

.68

.66

TLC:
rf deriv
carboxamide

.61

.61

TLC:
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DISCUSSION

This investigation commenced with the observation
in the clinical laboratory that colonization of the
respiratory tract by both Pseudomonas aeruginosa and
Candida albicans rarely occurred.

Coexistence, when ob¬

served, was for a brief interval.

Ultimately however, one

species would be pre-empted by the other; moreover, the
succession of species was observed to progress with
predictability from Candida to Pseudomonas.
During the past two decades, these organisms have
come to be recognized as opportunists and are being isolated
with increasing frequency from the immunologically in¬
competent or "compromised" host.

The unfavorable prognosis

given patients suffering from infections caused by these two
species arises from the lack of effective antimicrobial
agents and not from their inherent virulence.
in many cases,

Treatment,

is based on resolution of an underlying

disease or condition which generally accompanies these in¬
fections.

The possibility of manipulating antagonistic

interaction between these two organisms and its benefit was
an exciting prospect and prompted the present investigation.
The appearance of antagonism on culture plates of
clinical material is a common laboratory observation.
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Clinical specimens rarely yield growth of a single or¬
ganism; pathogens are often accompanied by indigenous
"contaminants" and culture plates incubated for 72 hours
reveal a microbial flora distinctly different from that
seen after 24 hours incubation.

Overgrowth of slower

growing species, the predominance of one species over
another and the effect of antibiotic therapy all contribute
to the phenomenon of apparent antagonism.

However, when

the preliminary observation of antagonism between Pseudo¬
monas and Candida was made these factors were discounted.
The colonial

characteristics of Candida and Pseudomonas

are strikingly different and in mixed cultures their
presence would be evident.

Both organisms grew readily on

simple media, producing distinct colonies after 24 hours
incubation.

Since Candida is relatively resistant to

antibiotics,

its suppression by these agents in clinical

specimens would be unlikely.
From these preliminary observations it was proposed
that Pseudomonas was antagonistic towards Candida.

The

associative culture studies indicated that the inhibition
of Candida was due to an antibiotic agent and not to
nutrient depletion or restrictive physiological conditions.
The "flip-flop" technique further confirmed this contention.
Since there was no direct contact between Candida and
Pseudomonas, the possibility that inhibition was due to
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phage particles was discounted.
The next observation was the appearance of
crystalline inclusions within colonies of Pseudomonas using
low microscopic magnification.

Various organic solvents

were added dropwise to these colonies to ascertain the
solubility of the crystals.

Chloroform was found to be a

very effective solvent for these crystals.
The experiments conducted during the filtrate
preparation stage of this study revealed that several anti¬
biotic pigments were produced during extended cultivation
of Ps. aeruginosa.

At least two of these pigments

were

found to be inhibitory to C. albicans and belonged to the
phenazine series of compounds.
It was determined however, that the yield of these
pigments could be more readily obtained from liquid cultures.
Stationary flasks incubated at 37 C for 2 to 4 days showed
development of a deep blue-green pigment in the upper layers
of the broth.

When the incubation was continued for 14

days, the bottom layer became greenish-yellow until finally
a yellow-brown color developed throught the medium.

At

the same time, a very evident intractable slime developed
throught the medium which disintegrated to some extent
during the extraction process.

Nevertheless,

it must be

removed by coarse filtration prior to membrane sterlization.
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The bioactive phenazine pigments obtained by
extraction were identified as phenazine-l-carboxylic acid
and pyocyanine.

These pigments were readily separated in

the extraction process by manipulating the pH of the spent
medium (generally 8.0 to 8.5 after 14 days).

After acidifi-

cation of the aqueous phase to pH 2.0, phenazine-l-carboxylic
acid formed a precipitate which was soluble in CHCl^.
Pyocyanine,

on the other hand, formed an insoluble pre¬

cipitate when the medium was made alkaline (pH

9) and

could be extracted with CHCly
Chromatographic separation at this point revealed
both extracts to be heterogeneous.

The extract containing

pyocyanine, developed on TLC plates, was accompanied by
six other bands as detected by ultraviolet light.

That

containing phenazine-l-carboxylic acid was accompanied by
seven other bands.

Bromcresol-blue spray, used to detect

carboxylic acids, was applied to developed plates and a
positive reaction indicated the position corresponding to
phenazine-l-carboxylic acid.

The organic nature of these

compounds was confirmed by charring with concentrated
sulphuric acid and heat.

Of all the bands produced, these

two were among the most prominent and when eluted were the
only ones exhibiting detectable antagonism towards Candida.
Though bioactivity was not detectable in the remaining
bands,

it is possible that several other phenazines were
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present.

Their concentration was perhaps too low to be

detectable by the assay method used.
Presently, about 3° phenazines have been isolated
from natural sources.

A literature search disclosed that

although pseudomonads are the most prominant source known;
Actinomycetes, algae and other diverse species synthesize
these compounds (1).

It has further been shown that anti¬

biotic effects are common with the phenazines and the
mechanism of action appears due to intercalation with
deoxyribonucleic acid

(13)•

The biosynthetic pathway of the phenazines has
been elucidated by Hellstein (12).

When radioactive labeled

shikimic acid was supplied to Ps. aeruginosa, 9% was
incorporated into phenazine-l-carboxylic acid and 7$ into
pyocyanine.

The structural formulas for these two compounds

is shown in Fig.4 •
The biological activity of these two phenazines
{

was found to be pH dependent.

Under acid conditions,

phenazine-l-carboxylic acid was apparently insoluble and
biologically inactive whereas the sodium salt of this acid
possessed marked activity, the inhibition zones produced
by the salt were distinctly clear with a discreet periphery
and could be accurately measured.

Furthermore, elution of

this compound from silica gel of the TLC plates was readily
accomplished with methyl alcohol containing 1 fo NH^OH or

COOH
N»

PHENAZINE 1 CARBOXYLIC

ACID

PYOCYANI NE

Figure

It.

Structural formulas of phenazine-l-carboxyli

acid and pyocyanine.
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0.1 N NaOH while methyl alcohol or CHCl^ alone were not
nearly as effective.
Pyocyanine is considered a neutral compound and
its bioactivity as a function of pH was not as evident as
that seen with phenazine-l-carboxylic acid.
and CHCl^ were both good solvents.

Methyl alcohol

Inhibition of Candida

as observed on overlay agar plates was less evident than that
seen with phenazine-l-carboxylic acid.
zone Candida1s presence was obvious.

Within the inhibition
The inhibition zones

of both compounds were examined under low magnification
(100 X) and Candida cells were readily observed:

the cell

population was greater in the case of pyocyaine and budding
was more obvious.

When these zones were subcultured on

fresh Sabourauds Dextrose agar, growth with original
vitality was regained.

This suggests that in the case of

Candida these compounds are fungi-static.
weak or dilute preparations,

Moreover, with

inhibition was difficult to

detect or was entirely overlooked.
When filter paper discs were impregnated with these
compounds and the discs placed in close proximity on the
overlay agar surface, approximately two centimeters apart,
a reinforcing effect was observed

(Fig. 4).

The asymmetric

inhibition pattern had the appearance of synergism, although
this was not investigated further.

The area around pyocya¬

nine was virtually without affect except where influenced
by phenazine-l-carboxylic acid.
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Fig. 5.
Apparent synergism between phenazine-1carboxylic acid and pyocyanine.
Note the asymmetric zone
of inhibition around the central disc containg phenazine-1
carboxylic acid caused by the nearest satellite disc con¬
taining pyocyanine.
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Another consideration was the biological activity
of these phenazines in-vivo and its relationship to pH.
Since antagonism appears to be dependent on an alkaline
environment,

it is conceivable that interaction might not

take place in the oral cavity or the vagina when these
habitats are excessively acidic (28).

The in-vitro

data at pH 6.0 and below showed complete loss of anticandidal activty (Table 2).

The concentration of serum

glucose and its conversion by the indigenous flora to acid
end-products may be the major determinant of an individual's
tendency to develop an infection by either one or both of
these organisms.

While Candida infections are commonly

associated with high concentrations of serum glucose, low
concentrations of this substrate accompanied by a more
neutral pH may favor the succession of Pseudomonas.
However, the measurable advantage to the patient
of a Pseudomonas rather than a Candida infection is highly
questionable.
disease,

Since both organisms are the cause of severe

it is inconceivable that modern medicine would

risk the purposeful introduction of one pathogen to
suppress another.
This report should reaffirm our respect for
opportunistic infections.

Evidence has been presented

here that suggests that these infections can occur in
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succession, Candida followed by Pseudomonas, each of which
is a test of the patient's immunological competence and
medicine's therapeutic capability.
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